Speaker Profile

M.D., Ph.D., CEO, HL7
Biography

Charles Jaffe is the CEO of HL7. He completed his medical training at Johns Hopkins and Duke Universities and post-doctoral training at NIH and the Lombardi Cancer Center. He served in various academic positions in the Departments of Medicine and in the School of Engineering. Previously, he was the Senior Global Strategist at Intel, led a national research consortium, found a consultancy for research informatics, served as the VP of Medical Informatics at AstraZeneca, and the VP of Life Sciences at SAIC. He was the contributing editor for several journals and has published on clinical research, informatics, and healthcare policy.

AI & Data Science Showcase: HL7
HL7 is a global, non-profit, ANSI standards organization providing a platform for exchanging electronic health data supporting clinical practice, research and health services.

Healthcare on FHIR: Innovation in Data Exchange & Analytics
HL7 FHIR is changing the way health data is shared, archived, repurposed and analyzed. FHIR provides a secure, simplified exchange platform that functions much like the internet. It ensures that implementers and app developers can innovate in an accessible, easily understood environment. FHIR has been deployed for clinical care, regulated research, population health, and integration of unique datasets, including genomics. All Federal agencies delivering healthcare have announced their support, including CMS, CDC, VA and FDA. Recently, Apple® announced the integration of FHIR into the HealthKit®. FHIR is implemented in over 2000 systems on 5 continents. Most importantly, FHIR is free.

Get Exclusive Access to the Top PMWC Talks

To receive the most comprehensive news and updates from the field of precision medicine, subscribe to the newsletter here.

Bonus for suscribing, you will get the access code for the top 3 talk videos from January's Precision Medicine World Conference.

You have successfully subscribed, you can access the talks here.